Drugs /
tetanus toxoid vaccine
Overview
Clinical Trials
Tetanus toxoid vaccine has been investigated in 3 clinical trials, of which 3 are open and 0 are closed. Of the trials investigating tetanus toxoid vaccine, 2 are phase 1/phase 2 (2 open) and 1 is phase 2 (1 open).
H3F3A K28M, HLA-A*02:01 Positive, and Hypodiploidy are the most frequent biomarker inclusion criteria for tetanus toxoid vaccine clinical trials.
Diffuse intrinsic pontine glioma, diffuse midline glioma, H3 K27M-mutant, and glioma are the most common diseases being investigated in tetanus toxoid vaccine clinical trials [2].
Drug Details
References
1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].
2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.